Double Bond Pharmaceutical International AB (DBP B) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Double Bond Pharmaceutical International AB

Why is Double Bond Pharmaceutical International AB ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-18.48%

EBIT Growth (5y)

11.35%

EBIT to Interest (avg)

-14.66

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.87

Sales to Capital Employed (avg)

0.20

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

0.47

EV to EBITDA

0.48

EV to Capital Employed

-0.23

EV to Sales

-2.18

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-60.46%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company

ROCE(HY)

Highest at 5.98%

OPERATING PROFIT(Q)

Highest at SEK -0.25 MM

PRE-TAX PROFIT(Q)

Highest at SEK -0.27 MM

NET PROFIT(Q)

At SEK -0.27 MM has Grown at 75.74%

-12What is not working for the Company

NET SALES(HY)

At SEK 0.08 MM has Grown at -65.03%

RAW MATERIAL COST(Y)

Grown by 50,027% (YoY

CASH AND EQV(HY)

Lowest at SEK 2.35 MM

DEBT-EQUITY RATIO (HY)

Highest at -7.68 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.14 times

Here's what is working for Double Bond Pharmaceutical International AB

Operating Profit

Highest at SEK -0.25 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Pre-Tax Profit

Highest at SEK -0.27 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Pre-Tax Profit

At SEK -0.27 MM has Grown at 75.74%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit

At SEK -0.27 MM has Grown at 75.74%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (SEK MM)

Here's what is not working for Double Bond Pharmaceutical International AB

Net Sales

At SEK 0.08 MM has Grown at -65.03%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (SEK MM)

Cash and Eqv

Lowest at SEK 2.35 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -7.68 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 0.14 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 50,027% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales